Orkambi 150-188 MG granule PKT 56S
Ended Awarded
- Contract number
- SPE2DB25FPRN4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,203
Award facts
- Contract value 100% obligated
- $33,203.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $33,203.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Orkambi 150-188 mg granule packets (56 count). This delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a single-line item procurement under the DLA's broader pharmaceutical supply framework. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Orkambi, a branded cystic fibrosis treatment, represents one of many specialty pharmaceutical products within the extensive portfolio covered by the IDC. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FPRN4?
SPE2DB25FPRN4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FPRN4 worth?
The government has obligated $33,203 on SPE2DB25FPRN4.
Is contract SPE2DB25FPRN4 an order under another contract?
Yes. SPE2DB25FPRN4 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRN4 competed?
The extent of competition for SPE2DB25FPRN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award